ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2279

Assessment Of Global Disease Activity In Rheumatoid Arthritis By Patients and Physicians: Cultural Differences Among Countries In The Meteor Database

E. Gvozdenovic1, R. Wolterbeek2, C.F. Allaart1, Claiton Brenol3, Arvind Chopra4, Maxime Dougados5, Paul Emery6, D. van der Heijde7, T.W.J. Huizinga1, Jonathan Kay8, Emilio Martín Mola9, Robert J. Moots10, José A. P. Da Silva11, Josef S. Smolen12, Douglas J. Veale13 and R. Landewe14, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Biostatistics, Leiden University Medical Center, Leiden, Netherlands, 3Universidade Federal do Rio Grande do Sul, Porto Alegre RS, Brazil, 4Rheumatology, Center for Rheumatic Diseases, Pune, India, 5Rheumatology B Department, Paris-Descartes University, Cochin Hospital, Paris, France, 6Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 7Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 8UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA, 9Rheumatology. La Paz Hospital. IdiPaz, Madrid, Spain, 10Clinical Sciences Centre, University of Liverpool, Liverpool, United Kingdom, 11Serviço de Reumatologia, Centro Hospitalar e Universitário de Coimbra – Hospitais da Universidade de Coimbra, E.P.E., Coimbra, Portugal, 12Medical University of Vienna, Vienna, Austria, 13Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland, 14Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, outcome measures and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Dissonant perceptions of disease activity between rheumatoid arthritis (RA) patients and their rheumatologists may influence treatment decisions. The discordance between patient’s and physician’s global disease activity assessment (PtGDA and PhGDA, respectively) may vary by country because of cultural differences. Our aim is to compare the differences between PtGDA and PhGDA among 13 countries in the METEOR database.

Methods: The Measurement of efficacy of Treatment in the Era of Rheumatology (METEOR) database, a worldwide online tool for disease monitoring in RA, was used to anonymously select 14,020 patients during the period between 2008 and 2012. PtGDA and PhGDA were scored independently on a 100 mm visual analogue scale (VAS) with 0 and 100 as extremes. Linear Mixed Models (LMM) were used to estimate the mean differences between PtGDA and PhGDA score in13 countries (Brazil, Czech Republic, Spain, France, United Kingdom , Ireland, Italy, Latvia, Mexico, Pakistan, Portugal, United States, and the Netherlands), adjusted for DAS. Generalized Estimated Equation (GEE) was used to model differences (>20mm) between PtGDA and PhGDA score as the outcome and countries as determinants, corrected for DAS.

Results: Mean difference between PtGDA and PhGDA score differs by country, varying from -2 mm (physician scores higher) in Mexico to 14 mm (patient scores higher) in Brazil (Figure 1), independent of DAS. GEE indicated that ‘country’ was a significant determinant of the difference between PtGDA and PhGDA score, independent of differences in DAS. With the Netherlands as a reference, PtGDA and PhGDA scores differ significantly within the same patient in almost all countries (Brazil, Czech Republic, Great Britain, Ireland, Italy, Latvia, Mexico, Pakistan, Portugal and United States).

Conclusion: We find differences between patients’ and physicians’ assessment of global disease activity, the magnitude of which varies depending upon the country in which the patient and the physician both reside. Cultural influences must be taken into account when interpreting discordances between the patient’s and the physician’s assessment of global disease activity in RA. Although the magnitude differs across countries, patients nearly always assess global disease activity to be worse than do their physicians.

                                                                               


Disclosure:

E. Gvozdenovic,
None;

R. Wolterbeek,
None;

C. F. Allaart,
None;

C. Brenol,
None;

A. Chopra,
None;

M. Dougados,
None;

P. Emery,
None;

D. van der Heijde,
None;

T. W. J. Huizinga,
None;

J. Kay,
None;

E. Martín Mola,
None;

R. J. Moots,
None;

J. A. P. Da Silva,
None;

J. S. Smolen,
None;

D. J. Veale,
None;

R. Landewe,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-global-disease-activity-in-rheumatoid-arthritis-by-patients-and-physicians-cultural-differences-among-countries-in-the-meteor-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology